Safety and Performance of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.
Also called NCT05115214
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Registry
-
NCT05115214
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Czechia
- Registry status
- Recruiting
Technical summary
Registry record NCT05115214. Allocation not applicable; no masking; primary purpose treatment. Start 2021-10-19 (actual); primary completion 2029-09-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Performance of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation
- Acronym
- SpherePVI
- Condition
- Atrial Fibrillation
- Intervention (Device)
- SpherePVI™ Catheter
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
Record details
- Record id
cardio:ct-nct05115214- Content hash
a3425bc68e33801c31a588f22253418b941513ab440fc4871d3b6be12ed0e186